Trimetazidine bulk supplier for pharma manufacturers

Trimetazidine 35 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 35 mg

Reference Brands: Vastarel MR (EU), Vastarel (UK)

Trimetazidine is a metabolic agent used in cardiology to improve heart function. It works by optimizing myocardial energy metabolism, helping the heart use glucose more efficiently under conditions of low oxygen. Trimetazidine is commonly prescribed for angina pectoris (chest pain due to reduced blood flow to the heart) and may be used as an adjunct therapy in patients with chronic stable angina.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Trimetazidine — third party manufacturing & bulk supply

Trimetazidine 35 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Trimetazidine is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Trimetazidine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Trimetazidine →

Back to Listing

Frequently Asked Questions

Trimetazidine is listed as Tablets in 35 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Trimetazidine is referenced against Vastarel MR (EU), Vastarel (UK). Reference brands are shown for identification only and remain the property of their respective trademark owners.